Penumbra, Inc. is a publicly traded medical device company founded in 2007 by Amir Khandani and headquartered in Alameda, California. The company specializes in the development and commercialization of minimally invasive medical devices for neurovascular intervention, including mechanical thrombectomy systems used in acute ischemic stroke treatment. Penumbra has grown to become a significant player in interventional neurovascular care, offering products for mechanical thrombectomy, embolization, and other neurovascular procedures. The company serves interventional radiologists, neurosurgeons, and other specialists globally across multiple countries. Listed on NASDAQ under ticker PEN, Penumbra combines innovation in device design with a focus on clinical outcomes for treating time-sensitive cerebrovascular conditions. The company's growth has been driven by both organic product development and strategic acquisitions in the neurovascular space.
92 open now, 92 first appeared in the last 30d.